Keywords

• Heparin sodium
• Enoxaparin sodium
• high quality heparin sodium

Quick Details

• ProName: Heparin sodium API CAS NO.9041-08-1
• CasNo: 9041-08-1
• Molecular Formula: (C12H16NS2Na3)20
• Appearance: white powder
• Application: Used in Synthesis, Pharmaceuticals
• DeliveryTime: within 7 days
• PackAge: bag or carton
• Port: xingang
• ProductionCapacity: 100 Kilogram/Day
• Purity: 99%
• Storage: Store in dry, dark and ventilated plac...
• Transportation: sea air
• LimitNum: 1 Kilogram

Superiority

• ProName: Heparin sodium API
• CasNo: 9041-08-1
• Molecular Formula: (C12H16NS2Na3)20
• Appearance: white or almost white powder
• Application: anticoagulant effect
• DeliveryTime: within 2 days after receiving the prep...
• PackAge: aluminum pot
• Port: qingdao
• ProductionCapacity: 100000 Kilogram/Year
• Purity: 99%
• Storage: 2-8 ℃
• Transportation: by air or by sea
• LimitNum: 1 Kilogram
• Valid Period: 3 years

Details

english name: heparin sodium

synonym: sodium heparin; sodium heparinate;reviparin sodium;porcine heparin sodium;bovine heparin sodium;enoxaparin sodium;hep, na, bovine;hep, na, porcine

cas no.: 9041-08-1

molecular formula: ca. (c12h16ns2na3)20

molecular weight: ca. 12000

store condition： 2-8°c

solubility： h2o: 50 mg/ml, clear, faintly yellow

form: crystalline (fine)

color: white

merck: 14,4653

stability: stable. incompatible with strong oxidizing agents, strong bases.

physical character:

white or gray-brown amorphous powder, odorless, tasteless, hygroscopic. soluble in water.

application: 　it is preventing the conversion of prothrombin into thrombin, anti-thrombosis effect for delay and prevents blood clotting, is the world's most effective and clinically largest amount of anti-clotting drugs, mainly used in cardiovascular disease and blood dialysis.

whether in vivo or in vitro, it has rapidly anticoagulant effect. major role in the formation of fibrin, can also reduce platelet aggregation. it can be used for the prevention and treatment of thromboembolic diseases, such as: myocardial infarction, pulmonary embolism, cerebral embolism, peripheral venous thrombosis, prevented thrombus